INTERNATIONAL PATENT: EMOVIAR PHARMACON GMBH, SCHEER, MATHIAS JOSEF FILES APPLICATION FOR "SUSTAINED RELEASE DOSAGE FORM FOR LOW SOLUBILITY COMPOUND TETRAHYDROCANNABINOL AND METHODS FOR PREPARING OF THIS SUSTAINED RELEASE DOSAGE FORM"

GENEVA, April 27 -- EMOVIAR PHARMACON GMBH (MerianstraBe 5379664 Wehr), SCHEER, Mathias Josef (MerianstraBe 5379664 Wehr) filed a patent application (PCT/EP2025/079658) for "SUSTAINED RELEASE DOSAGE FORM FOR LOW SOLUBILITY COMPOUND TETRAHYDROCANNABINOL AND METHODS FOR PREPARING OF THIS SUSTAINED RELEASE DOSAGE FORM" on Oct 14, 2025. With publication no. WO/2026/082747, the details related to the patent application was published on Apr 23, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): EMOVIAR PHARMACON GMBH (MerianstraBe 5379664 Wehr), SCHEER, Mathias Josef (MerianstraBe 5379664 Wehr)

Abst...